Latest filing published 28 Sept 2010 for MICRUS ENDOVASCULAR CORP.
No signal scores available.
Edward F. Ruppel Jr. discloses dealings in Micrus Endovascular Corp to SEC (Form 4). The record holds 13 filings, for trades running from 31 May 2007 to 27 September 2010.
Every open-market trade on record is a sale: 8 sales worth €295k. Besides market trades, the filings include 1 share grant and 3 option exercises. Since January 2010: no purchases and 6 sales on the market.
On 28 September 2010 came the latest disclosure, a transaction in Micrus Endovascular Corp. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations